Exane Derivatives’s Ross Stores ROST Stock Holding History

Exane Derivatives’s Portfolio ROST Stock Details ROST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-58,318	Closed	-$3.83M	–	663
2016 Q4	$3.83M	Buy	+58,318	New	+$3.82M	0.76%	42

Other funds holding ROST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Exane Derivatives's ROST Position: Q1 2017 in Review

Exane Derivatives sold out of Ross Stores (ROST) in Q1 2017, closing a stake of 58,318 shares — an estimated $3.83M sold.

Exane Derivatives first reported a position in ROST in Q4 2016 and held it in 1 quarter. The position peaked at $3.83M in Q4 2016. 707 funds tracked by Wall St. Rank hold ROST as of Q1 2017.

Exane Derivatives reported no remaining Ross Stores position as of Q1 2017 after selling out during the quarter.
Exane Derivatives sold 58,318 Ross Stores shares in Q1 2017, an estimated $3.83M.
Exane Derivatives first reported a position in Ross Stores in Q4 2016 and held it in 1 quarter.
Exane Derivatives's Ross Stores position peaked at $3.83M in Q4 2016.
707 funds tracked by Wall St. Rank held Ross Stores as of Q1 2017.

Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.